Role of monocytes in the pathogenesis of antiphospholipid syndrome and potential therapeutic targets (Review)
Authors:
Open Access
- 2 September 2025
- journal article
- review article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 32 (5) , 1-11
Abstract
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized primarily by arterial and/or venous thrombosis, obstetric complications and persistent positivity for antiphospholipid antibodies (aPLs). It has been proposed that the pathogenesis of APS is closely associated with vascular endothelial cell activation, complement activation and platelet activation. Notably, APS may be key to understanding the relationship between innate immune cells, and thrombosis and obstetric complications. Monocytes are activated by aPLs, adopting a pro‑inflammatory and pro‑coagulant phenotype, and producing inflammatory cytokines; however, the exact mechanisms of action of monocytes in APS remain unclear. Monocytes may act as an intermediary, triggering immune dysregulation, closely linking them to thrombosis and obstetric complications. Therefore, a better understanding of the potential pathogenic role of monocytes in APS is required, which could assist clinicians in gaining deeper insights into the pathogenesis of APS and identifying new therapeutic targets. This may provide new options for the management of APS. Therefore, the present study aimed to review monocytes and their role in APS.Keywords
This publication has 109 references indexed in Scilit:
- β2-glycoprotein I: antiphospholipid syndrome and T-cell reactivityThrombosis Research, 2004
- Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelinesLupus, 2003
- TNF‐α Protects Embryos Exposed to Developmental ToxicantsAmerican Journal of Reproductive Immunology, 2003
- Accumulation of CRTH2-positive T-helper 2 and T-cytotoxic 2 cells at implantation sites of human decidua in a prostaglandin D2-mediated mannerMolecular Human Reproduction, 2002
- RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic EndotheliumCirculation, 2001
- Hydroxychloroquine treatment for primary Sjögren's syndrome: its effect on salivary and serum inflammatory markersAnnals of the Rheumatic Diseases, 1999
- Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphos pholipid antibodies and recurrent spontaneous abortionAmerican Journal of Obstetrics and Gynecology, 1994
- Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells.Journal of Cell Biology, 1992
- Ligand bridging mediates integrin alpha IIb beta 3 (platelet GPIIB-IIIA) dependent homotypic and heterotypic cell-cell interactions.Journal of Clinical Investigation, 1991
- Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion.Journal of Clinical Investigation, 1989